Novo Holdings reported record income and returns in 2024, remaining a major shareholder of Novo Nordisk.

From StockTwits: 2025-04-02 09:56:00

Novo Holdings reported a record high total income and investment return of DKK 60 billion in 2024, nearly doubling from the previous year. The company’s earnings come from dividends, share repurchase programs, and investment portfolio returns. Novo Holdings manages the wealth of the Novo Nordisk Foundation, with its investment portfolio focusing on Life Science and Capital Investments. Despite a decline in assets under management due to market value fluctuations, Novo Holdings remains a major shareholder of Novo Nordisk. Novo Nordisk’s stock has faced challenges in the obesity drug market, impacting investor sentiment. Retail investors on Stocktwits express mixed feelings about the company’s performance.



Read more at StockTwits: Novo Nordisk’s Controlling Shareholder Novo Holdings Reports Record Total Income, Investment Returns In 2024: Retail Stays Bullish